Rochester, NY 9/2/2009 3:35:38 PM
Hemispherx Biopharma, Inc. HEB, Finished trading at 2.10
Hemispherx Biopharma, Inc.
StockEinstein.com offers free trading alerts on stocks about to run.To sign up for our free alert service please click here www.stockeinstein.com or scroll to bottom of this page to sign up.
Last Trade: 2.10
Day's Range: 2.06 - 2.54
Trade Time: Sep 1
52wk Range: 0.25 - 4.54
Change: Down -0.12 (-5.41%)
Volume: 23.38M
Prev Close: 2.10
Avg Vol (3m): 7.04M
Open: 2.40
Market Cap: 265.10M
About Hemispherx Biopharma, Inc.
Hemispherx Biopharma, Inc. (Hemispherx) is a biopharmaceutical company engaged in the clinical development, manufacture, marketing and distribution of new drug therapies based on natural immune system enhancing technologies for the treatment of viral and immune based chronic disorders. The Company’s products include Ampligen and Alferon N and Injection. Ampligen includes application as a treatment for Chronic Fatigue Syndrome (CFS) and as a vaccine enhancer(adjuvant) for both therapeutic and preventative vaccine development. Alferon N is an indicator for refractory or recurring genital warts. Alferon LDO (Low Dose Oral) is an application under early stage development targeting influenza and viral diseases. Ampligen is an experimental drug undergoing clinical development for the treatment of CFS.
About StockEinstein
StockEinstein.com uses proprietary technologies coupled with years of experience to uncover stocks we feel have the greatest potential for breakout performance. We utilize not only software, but time tested criteria to uncover these potential winners. When these benchmarks are reached or exceeded, our subscribers are immediately notified.
This service is free and available only to subscribers. Scroll down this page or visit our site to join our free newsletter and begin receiving daily stock alerts.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
